Skip to main content

Advertisement

SpringerLink
Log in

Inflammation-based prognostic scores in geriatric patients with rectal cancer

  • Original Article
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Background

Morbidity/mortality and oncologic outcomes can be worsened in geriatric rectal cancer patients due to comorbidities and frailty. The aim of this study was to compare surgical and oncological results of geriatric rectal cancer patients using inflammation-based prognostic scores.

Methods

The prospectively maintained database of 991 rectal cancer patients treated at our center between 2007 and 2020 were analyzed. All conventional clinicopathologic features, and oncologic outcomes are compared between patients ≥ 65 years old (geriatric patients: Group I) and < 65 years old (non-geriatric patients: Group II). The modified Glasgow Prognostic Score (mGPS) and the C-reactive protein-albumin ratio (CAR), were determined. The prognostic value of mGPS and CAR as well as the well-known clinico-pathologic factors to predict surgical morbidity, mortality, local and/or distant recurrence, and overall survival was assessed.

Results

There were 567 (57.2%) patients who were ≥ 65 years old (Group I; 349 males, median age 74 [range 65–9]) years) and 424 (42.8%) who were < 65 years old (Group II; 252 males, median age 58 [range 20–64] years). The high-grade [Clavien–Dindo III–IV] complications rates of Group I and Group II patients sere 20% (n = 113), and 9% (n = 37), respectively. High-grade complications were related to mGPS (p < 0.001) and CAR (p < 0.001) values. The high-grade complication rate was found to be higher in Group I than in Group II, and this was statistically significant (p < 0.001). High preoperative mGPS and CAR values were significantly associated with postoperative mortality (p < 0.001). In Cox multivariate analysis, mGPS (p = 0.003) and CAR (p = 0.001) were significantly in correlation with lowered overall survival. The mGPS and CAR were found to be independent prognostic factors for overall survival.

Conclusions

The mGPS and CAR can predict severe postoperative complications and early mortality. mGPS, and CAR have a powerful prognostic value and the potential clinical usefulness to predict decreased overall survival in both geriatric and non-geriatric rectal cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organization (2021) GLOBOCAN database https://gco.iarc.fr/today/home. Accessed 8 Mar 2021.

  2. Podda M, Sylla P, Baiocchi G, Adamina M, Agnoletti V et al (2021) Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian society of geriatric surgery), SIFIPAC (Italian society of surgical pathophysiology), SICE (Italian society of endoscopic surgery and new technologies), and the WSES (world society of emergency surgery) international consensus project. World J Emerg Surg 16:35. https://doi.org/10.1186/s13017-021-00378-9

    Article  PubMed  PubMed Central  Google Scholar 

  3. Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ et al (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 6(7):477–484. https://doi.org/10.1016/S1470-2045(05)70221-7

    Article  PubMed  Google Scholar 

  4. Kristjansson SR, Nesbakken A, Jordhoy MS, Skovlund E, Audisio RA, Johannessen HO et al (2010) Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol 76(3):208–217. https://doi.org/10.1016/j.critrevonc.2009.11.002

    Article  PubMed  Google Scholar 

  5. Korc-Grodzicki B, Downey RJ, Shahrokni A, Kingham TP, Patel SG, Audisio RA (2014) Surgical considerations in older adults with cancer. J Clin Oncol 32(24):2647–2653. https://doi.org/10.1200/JCO.2014.55.0962

    Article  PubMed  Google Scholar 

  6. Papamichael D, Audisio RA, Glimelius B et al (2015) Treatment of colorectal cancer in older patients: international society of geriatric oncology (SIOG) consensus recommendations 2013. Ann Oncol 26:46. https://doi.org/10.1093/annonc/mdu253

    Article  Google Scholar 

  7. Rutten HJT, den Dulk M, Lemmens VEPP, van de Velde CJH, Marijnen CAM (2008) Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 9(5):494–501. https://doi.org/10.1016/S1470-2045(08)70129-3

    Article  PubMed  Google Scholar 

  8. Hamaker ME, Te Molder M, Thielen N, van Munster BC, Schiphorst AH, van Huis LH (2018) The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients—a systematic review. J Geriatric Oncol 9(5):430–440. https://doi.org/10.1016/j.jgo.2018.03.014

    Article  Google Scholar 

  9. Fagard K, Leonard S, Deschodt M, Devriendt E, Wolthuis A, Prenen H et al (2016) The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: a systematic review. J Geriatric Oncol 7(6):479–491. https://doi.org/10.1016/j.jgo.2016.06.001

    Article  Google Scholar 

  10. Kang S, Wilkinson KJ, Brungs D, Chua W, Ng W, Chen J, Nasser E et al (2021) Rectal cancer treatment and outcomes in elderly patients treated with curative intent. Mol Clin Oncol 15(6):256. https://doi.org/10.3892/mco.2021.2418

    Article  PubMed  PubMed Central  Google Scholar 

  11. Thiels CA, Bergquist JR, Meyers AJ, Johnson CL, Behm KT, Hayman AV et al (2016) Outcomes with multimodal therapy for elderly patients with rectal cancer. Br J Surg 103(2):e106–e114. https://doi.org/10.1002/bjs.10057

    Article  CAS  PubMed  Google Scholar 

  12. Parks RM, Rostoft S, Ommundsen N, Cheung KL (2015) Peri-operative management of older adults with cancer-the roles of the surgeon and geriatrician. Cancers (Basel) 7(3):1605–1621. https://doi.org/10.3390/cancers7030853

    Article  CAS  PubMed  Google Scholar 

  13. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D et al (2014) EUROCARE-5 working group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 e a population-based study. Lancet Oncol 15:23–34. https://doi.org/10.1016/S1470-2045(13)70546-1

    Article  PubMed  Google Scholar 

  14. Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS et al (2018) Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut 67(1):179–193. https://doi.org/10.1136/gutjnl-2017-315333

    Article  PubMed  Google Scholar 

  15. Wildiers H, Heeren P, Puts M et al (2014) International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595–2603. https://doi.org/10.1200/JCO.2013.54.8347

    Article  PubMed  PubMed Central  Google Scholar 

  16. Williams GR, Deal AM, Jolly TA et al (2014) Feasibility of geriatric assessment in community oncology clinics. J Geriatric Oncol 5:245. https://doi.org/10.1016/j.jgo.2014.03.001

    Article  Google Scholar 

  17. Sourdet S, Brechemier D, Steinmeyer Z, Gerard S, Balardy L (2020) Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology. BMC Cancer 20(1):384. https://doi.org/10.1186/s12885-020-06878-2

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ferrat E, Paillaud E, Caillet P, Laurent M, Tournigand C et al (2017) Performance of four frailty classifications in older patients with cancer: prospective elderly cancer patients cohort study. J Clin Oncol 35(7):766–777. https://doi.org/10.1200/JCO.2016.69.3143

    Article  PubMed  PubMed Central  Google Scholar 

  19. Dogrul RT, Dogrul AB, Konan A, Caglar O, Sumer F (2020) Does preoperative comprehensive geriatric assessment and frailty predict postoperative complications? World J Surg 44(11):3729–3736. https://doi.org/10.1007/s00268-020-05715-8

    Article  PubMed  Google Scholar 

  20. Michaan N, Park SY, Lim MC (2020) Comprehensive geriatric assessment is correlated to overall survival among gynaecologic oncology patients. Jpn J Clin Oncol 50(3):276–281. https://doi.org/10.1093/jjco/hyz178

    Article  PubMed  Google Scholar 

  21. Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H (2018) Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev 64:30–39. https://doi.org/10.1016/j.ctrv.2018.02.003

    Article  PubMed  Google Scholar 

  22. Hamaker ME, Prins MC, Schiphorst AH, van Tuyl SA, Pronk A, van den Bos F (2015) Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol 6(2):153–164. https://doi.org/10.1016/j.jgo.2014.10.001

    Article  PubMed  Google Scholar 

  23. Church S, Rogers E, Rockwood K, Theou O (2020) A scoping review of the clinical frailty scale. BMC Geriatr 20(1):393. https://doi.org/10.1186/s12877-020-01801-7

    Article  PubMed  PubMed Central  Google Scholar 

  24. Pages F, Kirilovsky A, Mlecnik B et al (2009) In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 27:5944–5951. https://doi.org/10.1200/JCO.2008.19.6147

    Article  CAS  PubMed  Google Scholar 

  25. Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT et al (2018) International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391(10135):2128–2139. https://doi.org/10.1016/S0140-6736(18)30789-X

    Article  PubMed  Google Scholar 

  26. Diakos CI, Charles KA, McMillan DC et al (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15:e493-503. https://doi.org/10.1016/S1470-2045(14)70263-3

    Article  PubMed  Google Scholar 

  27. McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39(5):534–540. https://doi.org/10.1016/j.ctrv.2012.08.003

    Article  PubMed  Google Scholar 

  28. Dolan RD, McSorley ST, Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC (2018) The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer 119(1):40–51. https://doi.org/10.1038/s41416-018-0095-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC (2013) Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow inflammation outcome study. Cancer 119(12):2325–2332. https://doi.org/10.1002/cncr.28018

    Article  CAS  PubMed  Google Scholar 

  30. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K (2013) Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer. Am J Surg 205(1):22–28. https://doi.org/10.1016/j.amjsurg.2012.04.012

    Article  PubMed  Google Scholar 

  31. Cavallaro P, Bordeianou L (2019) Implementation of an ERAS pathway in colorectal surgery. Clin Colon Rectal Surg 32:102–108. https://doi.org/10.1055/s-0038-1676474

    Article  PubMed  PubMed Central  Google Scholar 

  32. Barberan-Garcia A, Ubré M, Roca J, Lacy AM, Burgos F, Risco R, Momblán D, Balust J, Blanco I, Martínez-Pallí G (2018) Personalised pre-habilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial (2018). Annal Surg 267(1):50–56. https://doi.org/10.1097/SLA.0000000000002293

    Article  Google Scholar 

  33. Rooijen SV, Carli F, Dalton S, Thomas G, Bojesen R et al (2019) Multimodal pre-habilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal pre-habilitation. BMC Cancer 19(1):98. https://doi.org/10.1186/s12885-018-5232-6

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ommundsen N, Wyller TB, Nesbakken A, Bakka AO, Jordhoy MS, Skovlund E et al (2018) Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial. Colorectal Dis 20(1):16–25. https://doi.org/10.1111/codi.13785

    Article  CAS  PubMed  Google Scholar 

  35. Suhool A, Moszkowicz D, Cudennec T, Vychnevskaia K, Malafosse R, Beauchet A, Julié C, Peschaud F (2018) Optimal oncologic treatment of rectal cancer in patients over 75 years old: results of a strategy based on oncogeriatric evaluation. J Visc Surg 155(1):17–25. https://doi.org/10.1016/j.jviscsurg.2017.06.005

    Article  CAS  PubMed  Google Scholar 

  36. Moureau-Zabotto L, Resbeut M, Gal J et al (2013) Management and clinical outcome of rectal cancer in patients >/= 80 years treated in southern France (PACA region) between 2006 and 2008. J Surg Oncol 108:450–456. https://doi.org/10.1002/jso.23428

    Article  CAS  PubMed  Google Scholar 

  37. Rostoft S, Hamaker ME (2020) Basic geriatric principles for colorectal surgeons: how to optimize assessment and care of the elderly in the perioperative period. Eur J Surg Oncol 46(3):310–315. https://doi.org/10.1016/j.ejso.2019.07.027

    Article  CAS  PubMed  Google Scholar 

  38. Lin HS, Watts JN, Peel NM, Hubbard RE (2016) Frailty and post-operative outcomes in older surgical patients: a systematic review. BMC Geriatr 16(1):157. https://doi.org/10.1186/s12877-016-0329-8

    Article  PubMed  PubMed Central  Google Scholar 

  39. Souwer ETD, Hultink D, Bastiaannet E, Hamaker ME, Schiphorst A, Pronk A, Van der Bol JM, Steup WH, Dekker JWT, Portielje JEA, van den Bos F (2019) The prognostic value of a geriatric risk score for older patients with colorectal cancer. Ann Surg Oncol 26(1):71–78. https://doi.org/10.1245/s10434-018-6867-x

    Article  CAS  PubMed  Google Scholar 

  40. Ketelaers SHJ, Fahim M, Rutten HJT, Smits AB, Orsini RG (2020) When and how should surgery be performed in senior colorectal cancer patients? Eur J Surg Oncol 46(3):326–332. https://doi.org/10.1016/j.ejso.2020.01.007

    Article  CAS  PubMed  Google Scholar 

  41. Hathout L, Maloney-Patel N, Malhotra U, Wang SJ, Chokhavatia S, Dalal I et al (2018) Management of locally advanced rectal cancer in the elderly: a critical review and algorithm. J Gastrointest Oncol 9(2):363–376. https://doi.org/10.21037/jgo.2017.10.10

    Article  PubMed  PubMed Central  Google Scholar 

  42. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123. https://doi.org/10.1056/NEJMoa060829

    Article  CAS  PubMed  Google Scholar 

  43. Gérard JP, Azria D, Gourgou-Bourgade S et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-prodige 2. J Clin Oncol 28:1638–1644. https://doi.org/10.1200/JCO.2009.25.8376

    Article  CAS  PubMed  Google Scholar 

  44. Gérard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620–4625. https://doi.org/10.1200/JCO.2006.06.7629

    Article  PubMed  Google Scholar 

  45. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223. https://doi.org/10.1002/bjs.5506

    Article  CAS  PubMed  Google Scholar 

  46. Guerin O, Gal J, Francois E et al (2012) Clinical outcome of rectal cancer in patients ≥ 80 years treated in southern France (PACA region) between 2002 and 2005. Strahlenther Onkol 188:383–387. https://doi.org/10.1007/s00066-012-0076-5

    Article  CAS  PubMed  Google Scholar 

  47. Montroni I, Ugolini G, Nicole Saur NM, Spinelli A, Rostoft S et al (2018) Personalized management of elderly patients with rectal cancer: expert recommendations of the European society of surgical oncology, European society of coloproctology, international society of geriatric oncology, and American college of surgeons commission on cancer. Eur J Surg Oncol 44(11):1685–1702. https://doi.org/10.1016/j.ejso.2018.08.003

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deparment of General Surgery, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

    B. Manoglu, S. Sokmen & T. Bisgin

  2. Department of Medical Oncology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

    H. S. Semiz

  3. Department of Radiation Oncology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

    İ. B. Görken

  4. Department of Biostatistics and Medical Informatics, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

    H. Ellidokuz

Authors
  1. B. Manoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sokmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Bisgin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. S. Semiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. İ. B. Görken
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Ellidokuz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Manoglu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Approval was obtained from the ethics committee of Dokuz Eylul University Faculty of Medicine for the retrospective analysis of patient data (Reference No: 2022/20–18).

Informed consent

After obtaining the non-invasive ethics committee approval required for retrospective studies, formal constent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manoglu, B., Sokmen, S., Bisgin, T. et al. Inflammation-based prognostic scores in geriatric patients with rectal cancer. Tech Coloproctol 27, 397–405 (2023). https://doi.org/10.1007/s10151-022-02710-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-022-02710-0

Keywords

Search

Navigation